Sabia E B, Tominaga M, Paiva A C, Paiva T B
J Med Chem. 1977 Dec;20(12):1679-81. doi: 10.1021/jm00222a030.
The structural requirements for prolonged residual ("sensitizing") activity in bradykinin-potentiating peptides (BPP's) were investigated through a study of seven synthetic BPP's including three not previously described: [Lys6]-BPP9a, [Gly6]potentiator B, and [Lys6,Gln8]potentiator B. The quantitation of the sensitizing activities in the isolated guinea pig ileum indicated that the structural requirements for bradykinin potentiation and for sensitization were not the same. The most potent sensitizers were potentiator B and [Lys6]-BPP9a.
通过对七种合成缓激肽增强肽(BPP's)进行研究,包括三种此前未描述的:[Lys6]-BPP9a、[Gly6]增强剂B和[Lys6,Gln8]增强剂B,来研究缓激肽增强肽(BPP's)中延长残留(“致敏”)活性的结构要求。对分离的豚鼠回肠中致敏活性的定量分析表明,缓激肽增强和致敏的结构要求并不相同。最有效的致敏剂是增强剂B和[Lys6]-BPP9a。